Placenta Compositum (Heel Inc)
Welcome to the PulseAid listing for the Placenta Compositum drug offered from Heel Inc. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Heel Inc |
| NON-PROPRIETARY NAME: | HORSE CHESTNUT and LACTIC ACID, L- and CLAVICEPS PURPUREA SCLEROTIUM and CUPRIC SULFATE and MELILOTUS OFFICINALIS TOP and SUS SCROFA PLACENTA and SOLANUM NIGRUM WHOLE and STROPHANTHUS HISPIDUS SEED an |
| SUBSTANCE NAME: | HORSE CHESTNUT; LACTIC ACID, L-; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; MELILOTUS OFFICINALIS TOP; SUS SCROFA PLACENTA; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA EMBRYO; SOD |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient] |
| ROUTE: | INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2009-04-30 |
| END MARKETING DATE: | 0000-00-00 |
Placenta Compositum HUMAN PRESCRIPTION DRUG Details:
| Item Description | Placenta Compositum from Heel Inc |
| LABELER NAME: | Heel Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4; 4; 4; 6; 6; 6; 6; 6; 8; 8; 8; 10; 10; 10; 10; 13; 18([hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_) |
| START MARKETING DATE: | 2009-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50114-7055_cc3f0e8b-fc8c-4a62-b3e7-d70b061977e4 |
| PRODUCT NDC: | 50114-7055 |
| APPLICATION NUMBER: | |
Other HORSE CHESTNUT; LACTIC ACID, L-; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; MELILOTUS OFFICINALIS TOP; SUS SCROFA PLACENTA; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA EMBRYO; SOD Pharmaceutical Manufacturers / Labelers:
